47th week of 2009 patent applcation highlights part 32 |
Patent application number | Title | Published |
20090285698 | DIAPHRAGM PUMP - A pump is provided including a housing and a plurality of diaphragm assemblies radially disposed within the housing, each diaphragm assembly of the plurality of diaphragm assemblies including a diaphragm. A drive element is configured to be eccentrically coupled to a rotating shaft motor to actuate the diaphragm for each of the plurality of diaphragm assemblies to draw fluid into or expel fluid from the diaphragm assembly. The drive element includes a first member and a plurality of second members, each second member of the plurality of second members being movably secured to the first member and disposed between the first member and the diaphragm of each of the plurality of diaphragm assemblies. During actuation of each diaphragm of the plurality of diaphragm assemblies, the corresponding first member and second member provide a continuously rigid radial coupling with the diaphragm. | 2009-11-19 |
20090285699 | MOTOR AND FAN APPARATUS HAVING THE MOTOR - An electric motor includes a stator portion, a rotor portion, and a bearing mechanism, wherein the rotor portion includes a rotor holder having a substantially cylindrical shape with a closed end, and a field magnet fixed to an inner circumference of the rotor holder; the stator portion includes a stator, a base portion to which the stator is fixed, and a magnetic member; and the magnetic member includes a cylindrical portion having a substantially cylindrical shape into which a lower end portion of an insulator of the stator is inserted, the lower end portion being a portion of an outer portion of the insulator and opposing the base portion, and a flat portion having a substantially annular shape which spreads outwardly in a radial direction from a lower edge of the cylindrical portion and opposes a lower edge of the field magnet. | 2009-11-19 |
20090285700 | LOW RATE HYDRAULIC ARTIFICIAL LIFT - In an embodiment of the invention, a down-hole pump comprises a hydraulic chamber having a passage for fluid communications with a hydraulic conduit, a produced fluid chamber having an inlet and an outlet, a first check valve associated with the inlet, a second check valve associated with the outlet, a stored energy unit, a piston, having one side exposed to the stored energy unit and a second side exposed to the hydraulic chamber and a displacement member projecting from said piston into the produced fluid chamber. Additional embodiments and aspects, including embodiments for power units as well as system and method aspects, are also disclosed. | 2009-11-19 |
20090285701 | HERMETIC TYPE COMPRESSOR - A hermetic type compressor is provided in which suction port is offset arranged in the rotating direction side of rotor from the upstream of suction port with respect to the flow of the cooling medium at the front of suction port with respect to opening of suction tube, so that low-temperature cooling medium is supplied from the upstream of suction port with respect to the flow of the cooling medium at the front of suction port, the low-temperature cooling medium is efficiently suctioned from suction port, and the low-temperature cooling medium is supplied to cylinder. | 2009-11-19 |
20090285702 | COMPRESSOR - A discharge port of a compression element is positioned inside an outer circumferential surface of a stator, as seen looking in a direction of a rotation axis of a shaft, and overlaps the stator, as seen looking in a direction orthogonal to the rotation axis of the shaft. Accordingly, refrigerant gas discharged from the compression element can be made to flow mainly into spaces inside the outer circumferential surface of the stator. | 2009-11-19 |
20090285703 | Motor-Driven Compressor - An energization bolt ( | 2009-11-19 |
20090285704 | OIL-LESS AIR COMPRESSOR - The present invention provides an air compressor, characterized in that the piston head has a concave portion having a plurality of through holes therein and a reed piece having a smaller area than that of said concave portion is disposed in said concave portion, said reed piece having an opening in its center to allow a seizing member, respectively, which is seized on a top center of said piston head, for freely moving through said opening, and said seizing member having a confining portion to confine said reed piece within a predetermined space for moving so that said reed piece moves toward or away from said plurality of through holes by means of reciprocally moving said piston rod to improve the air compression efficiency while said air compressor is operating. | 2009-11-19 |
20090285705 | Tube Pump And Liquid Ejection Apparatus - A flexible tube has a first portion and a second portion located close to each other in the vicinity of an opening of an accommodating case. A pressing member moves from the first portion to the second portion along the tube while pressing a portion of the tube. An assistant member is provided in the vicinity of the opening of the case. The assistant member has an assistant surface. When the pressing member passes the vicinity of the opening of the case, the assistant member transfers the pressing member from the second portion to the first portion via the assistant surface. This structure ensures a silent operation of the tube pump. | 2009-11-19 |
20090285706 | Peristaltic pump with removable tube - A peristaltic pump comprising a casing defining a tube race, a flexible tube disposed in said tube race, and a rotor with one or more rollers adapted to act against the flexible tube, in which the casing comprises a first section comprising said tube race and a first part of fitting means, and a second section comprising said rotor and a second part of said fitting means, in which the first and second parts of said fitting means are a releasable snap-fit together. | 2009-11-19 |
20090285707 | Variable Capacity Pump with Dual Springs - In a traditional variable-displacement vane pump, at lower speeds the pump will often operate at a higher capacity than necessary for that speed, thus wasting energy. A variable capacity vane pump ( | 2009-11-19 |
20090285708 | SCROLL TYPE COMPRESSOR - A scroll type compressor has a fixed scroll member, a movable scroll member, an oil reservoir, a back-pressure chamber, an oil extraction passage, a flow passage, and a partition wall. The back-pressure chamber disposed behind the movable scroll member is in communication with a discharge chamber. The oil extraction passage having a regulating valve or a throttle connects the back-pressure chamber to the oil reservoir. The oil return passage and the flow passage connect the oil reservoir to a suction chamber, respectively. The flow passage introduces excess lubricating oil into the suction chamber when the level of lubricating oil in the oil reservoir becomes higher than a predetermined level. The partition wall disposed between the openings of the oil extraction passage for restricting lubricating oil from the oil extraction passage other than the excess lubricating oil collected in the oil reservoir from flowing to the flow passage. | 2009-11-19 |
20090285709 | Vane pump - A vane pump comprising a case, a rotor disposed in the case, the rotor having a bore, a plurality of vanes radially moveable with respect to the rotor extend from the rotor, a drive shaft engaged with the bore, a second shaft fixedly connected to the case and extending from the case to slidingly engage the bore, a land extending from each end of the rotor, each land cooperating with the case to seal a fluid flow, and each land further axially controlling a rotor position within the case by a sliding engagement, and the drive shaft retainable in a predetermined position with respect to the case. | 2009-11-19 |
20090285710 | Compressor Unloading Valve - A compressor ( | 2009-11-19 |
20090285711 | FLUID MACHINE - A housing of a Roots pump is configured by joining a lower housing member and an upper housing member that are separable from each other. With the upper and lower housing members joined together, an upper accommodating portion and a lower accommodating portion form a front bearing accommodating portion and a rear bearing accommodating portion, which accommodate whole bearings, respectively. The Roots pump further includes bearing holders attached to the bearings and fixed to the lower housing member so that the bearings are received in the lower accommodating portion in a positioned state. | 2009-11-19 |
20090285712 | METAL POWDER - The present invention relates to a metal powder mixture that is suitable for producing sintered bodies. The powder mixture is suitable as a binder for hard metals and contains: a) at least one prealloyed powder selected from the group of iron/nickel, iron/cobalt, iron/nickel/cobalt and nickel/cobalt; b) at least one element powder selected from the group of iron, nickel and cobalt or a prealloyed powder selected from the group consisting of iron/nickel, iron/cobalt, iron/nickel/cobalt and nickel/cobalt which is different from component a). The invention also relates to a cemented hard material which uses the inventive powder mixture and a hard material powder, wherein the overall composition of the components a) and b) together contains not more than 90% by weight of cobalt and not more than 70% by weight of nickel and the iron content. | 2009-11-19 |
20090285713 | LOW ALLOY STEEL FOR HIGH-PRESSURE HYDROGEN GAS ENVIRONMENT AND CONTAINER FOR HIGH-PRESSURE HYDROGEN - Provided is a low alloy steel for high-pressure hydrogen gas environments, which contains, by mass percent, C: 0.15 to 0.60%, Si: 0.05 to 0.5%, Mn: 0.05 to 3.0%, P: not more than 0.025%, S: not more than 0.010%, Al: 0.005 to 0.10%, Mo: 0.5 to 3.0%, V: 0.05 to 0.30%, O (oxygen): not more than 0.01%, N: not more than 0.03%, and the balance Fe and impurities, and has tensile strength of not less than 900 MPa. This low alloy steel desirably contains B of 0.0003 to 0.003%, but in this case, N is limited to not more than 0.010%. It is desirable to contain at least one among Cr, Nb, Ti, Zr, and Ca. The contents of Mo and V desirably satisfy the following formula (1): | 2009-11-19 |
20090285714 | Implantable medical Devices Composed of a Radiopaque Alloy and Method of Making the Alloy - Implantable medical devices made from a single beta phase Tantalum alloy utilizing Titanium as an alloying agent that are biocompatible, radiopaque and visible under x-ray and fluoroscopy, the alloy having mechanical properties that allow it to be machined by conventional, machining methods for forming the devices, and a method for making the alloy. The alloy is between approximately 10 percent and 25 percent Ti by weight and preferably has a density of 12 g/cm | 2009-11-19 |
20090285715 | Welding Additive Material, Welding Methods And Component - The invention relates to a welding additive material, a use of a welding additive material, welding methods and a component which significantly improves the weldability of some nickel-based superalloys by means of a welding additive material and comprises the following constituents (in wt %): 18.0%-20.0% of chromium, 9.0%-11.0% of cobalt, 7.0%-10.0% of molybdenum, 2.0%-2.5% of titanium, 1.0%-1.7% of aluminum, 0.04%-0.08% of carbon, balance nickel. | 2009-11-19 |
20090285716 | PROCESS FOR RECYCLING ALUMINIUM ALLOY SCRAP COMING FROM THE AERONAUTICAL INDUSTRY - A manufacturing process for a remelt block containing aluminum designed for making aluminum alloy for the aircraft industry in which scrap containing mainly aluminum alloys used in the aircraft industry is supplied during a supply stage, the scrap is melted in a smelting furnace in order to obtain an initial molten metal bath during a smelting stage, the initial molten metal bath is subjected to purification by fractional crystallization in order to obtain a solidified mass and a bath of residual liquid during a segregation stage, and the solidified mass is recovered in order to obtain a remelt block during a recovery stage. The invention is particularly useful for the recycling of aluminum alloys used in the aircraft industry as it makes it possible to purify scrap of series 2XXX or series 7XXX alloys for iron and silicon, without eliminating additive elements such as zinc, copper and magnesium. | 2009-11-19 |
20090285717 | Iron-Nickel-Chrome-Silicon-Alloy - Iron-nickel-chromium-silicon alloy having (in % by weight) 34 to 42% nickel, 18 to 26% chromium, 1.0 to 2.5% silicon, and additives of 0.05 to 1% Al, 0.01 to 1% Mn, 0.01 to 0.26% lanthanum, 0.0005 to 0.05% magnesium, 0.01 to 0.14% carbon, 0.01 to 0.14% nitrogen, max. 0.01% sulfur, max. 0.005% B, remainder iron and the usual impurities resulting from the production process. | 2009-11-19 |
20090285718 | Polymer Active Complex Fibers - The invention comprises a method of forming functionally active fibers and substrates comprising functionally active fibers. The method includes forming a mixture of at least one poly vinyl polymer and at least one bleaching active. The mixture is then injected at a controlled flow rate into an electric field to cause the mixture to at least partially form fine fibers that have an average diameter of less than about 1000 nanometers. | 2009-11-19 |
20090285719 | Compressible Transparent Sealing for Open Microplates - An apparatus for sealing a microplate, wherein the apparatus comprises a microplate having a first surface and an opposing second surface. A plurality of wells is formed in the first surface of the microplate, wherein each of the plurality of wells is sized to receive an assay therein. A sealing cover is disposed over the microplate adjacent the plurality of wells and is compliant to accommodate variations between the sealing cover and the microplate and/or distribute loads evenly therebetween. | 2009-11-19 |
20090285720 | CHANNEL SUBSTRATE - The present application provides a channel substrate has a channel provided therein and includes a plurality of detection portions configured to detect a specimen in the channel using an optical means, an introducing portion configured to introduce the specimen into the channel, and a discharging portion configured to discharge the specimen from the channel. The detection portions have, on at least one of the opposite faces of the channel substrate, detection portion surfaces which have distances different from each other to the channel. | 2009-11-19 |
20090285721 | Apparatus for chemical analysis of a sample - The present invention provides an apparatus for the chemical analysis of a sample. | 2009-11-19 |
20090285722 | Collection container assembly with nanocomposite barrier coating - An evacuated container assembly suitable for use in connection with blood collection including: (a) a container member formed of a first polymeric material and having a sidewall and one or more openings; (b) a nanocomposite barrier coating disposed on the container member having a thickness of up to about 30 microns and being derived from an aqueous dispersion including (i) a dispersed barrier matrix polymer; and (ii) a substantially exfoliated silicate filler having an aspect ratio of more than 50; and (c) one or more sealing members disposed in the opening(s) operative to hermetically seal the cavity; wherein the cavity is evacuated and maintains a pressure below atmospheric pressure and exhibits a draw volume loss lower than that of a like assembly without a nanocomposite barrier film by a factor of at least 1.5. | 2009-11-19 |
20090285723 | Sample Container Holder - The present invention provides a sample container holder for securely holding sample containers of various shapes and sizes. The holder comprises a base having at least one slot extending from an upper portion of the base to a lower portion of the base. The holder further comprises at least one retainer inserted into the slot creating at least a partial enclosed area on the base to accommodate the sample container. | 2009-11-19 |
20090285724 | Exhaust Device for a Diesel Engine - A flammable-gas led-out pipe ( | 2009-11-19 |
20090285725 | Apparatus and Method for Rapid and Continuous Generation of Phosphine Gas - Phosphine gas is generated by agitating a reaction mixture of a metal phosphide and water with agitation air in a reaction pot of a phosphine gas generator. The resulting phosphine gas is then diluted with dilution air to produce a fumigant phosphine gas which is directly delivered to a commodity for fumigation. The reaction pot does not have any rotating means such as agitators, rotors, or stirrers. The generator provides on-site generation of phosphine gas in a rapid manner improving the fumigation efficiency for a commodity, such as grain, preferably contained within a storage structures, such as a grain silo. The generator has a built in deactivation system for the unused metal phosphide and phosphine gas. | 2009-11-19 |
20090285726 | HOLDING SEALING MATERIAL, METHOD FOR MANUFACTURING HOLDING SEALING MATERIAL AND EXHAUST GAS PURIFYING APPARATUS - A holding sealing material includes a needle mat, a sheet-processed mat, and a sheet-processed mat. The needle mat includes entangled first inorganic fibers and a binder. The sheet-processed mat includes a binder and second inorganic fibers processed into a sheet. The needle mat and the sheet-processed mat are laminated together. Staple fibers having an average fiber length shorter than an average fiber length of the second inorganic fibers are localized in an interface area extending inside the needle mat from an interface between the needle mat and the sheet-processed mat. A binder content of the interface area is higher than a binder content of the needle mat in terms of weight ratio. | 2009-11-19 |
20090285727 | ILLUMINATION UNIT FOR LIQUID DISINFECTION SYSTEMS - Some demonstrative embodiments of the invention include an illumination-based liquid disinfection device. The disinfection device may include, for example, a conduit to carry a flowing liquid to be disinfected, the conduit having an inlet to receive the liquid and an outlet to discharge the liquid, one or more UV transparent sleeves having a hydro-dynamic shape and one or more UV light sources, each positioned within its respective protective sleeve. | 2009-11-19 |
20090285728 | ISOLATION AND SUBSEQUENT UTILIZATION OF SATURATED FATTY ACIDS AND ALPHA-OLEFINS IN THE PRODUCTION OF ESTER-BASED BIOLUBRICANTS - The present invention is generally directed to the synthesis and/or manufacture of ester-based lubricant compositions. The present invention is also directed to methods of making these and other similar lubricant compositions, and to systems for implementing such methods (processes). In some embodiments, the methods for making such ester-based lubricants utilize a biomass precursor (e.g., triglyceride-bearing vegetable oils) such that the lubricant compositions generated by the methods and systems of the present invention can be properly deemed biolubricants. In these or other embodiments, lubricant precursor species can also be sourced or derived from Fischer-Tropsch (FT) and/or long-chain paraffin pyrolysis reaction products. The ester component of the lubricant compositions, produced in accordance with the methods and systems of the present invention, comprises largely diester species. | 2009-11-19 |
20090285729 | Enhanced bed separation in a styrene monomer reactor using milled plates - An apparatus for use in radial flow reactors is presented. The apparatus includes a plate of sufficient thickness to impart strength in supporting a solid particle bed, and is milled to have narrow slots allowing the flow of fluid through the plate, while preventing the passage of catalyst through the plate. | 2009-11-19 |
20090285730 | Internal Grids for Adsorbent Chambers and Reactors - A milled plate is presented that is provided for use in a radial flow reactor. The milled plate has narrow slots milled in the plate on the solid particle side and slots of slightly greater width milled on the fluid side of the plate. The plates provide strength to support the pressure from solid particles that currently is not present in wire screen meshes. | 2009-11-19 |
20090285731 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) - Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. | 2009-11-19 |
20090285732 | Optimized Counter-Current Flow Baffle - A new reactor design is presented for a counter-current flowing reactor. The reactor has a catalyst flowing down through the reactor, and over baffles. Gas is admitted under the baffles and flows up through the solid catalyst bed. The design includes slotted plates that extend from the bottom of the baffle in the reactor to a position near the catalyst outlet. The gas flows through the slotted plates and is directed up through the catalyst bed, while directing the flowing catalyst to the catalyst outlet ports. | 2009-11-19 |
20090285733 | COMPOSITE ARTICLE AND RELATED METHOD - A method for making a composite includes combining a strengthening agent and an aluminum compound to form a first solution; precipitating an Al(OH) | 2009-11-19 |
20090285734 | CATALYST FOR GENERATING OXIDIZED MERCURY FOR TESTING MERCURY CONTINUOUS EMISSION MONITORS (CEM) - The present invention discloses a catalyst, system, and process for oxidizing mercury. The catalyst can include a substrate and a layer attached to at least part of the substrate. The layer contains a noble metal and has an average thickness of less than 100 nanometers. The substrate can be a plurality of glass fibers that provides for a relatively high surface area for the layer to be attached to. In the alternative, the substrate can be a porous substrate that provides for a high surface area for the layer to be attached to. | 2009-11-19 |
20090285735 | SELECTIVE CATALYTIC REDUCTION SYSTEM AND PROCESS USING A PRE-SULFATED ZIRCONIA BINDER - A selective catalytic reduction (SCR) process with a palladium catalyst for reducing NO | 2009-11-19 |
20090285736 | Catalytic Soot Filter and Use Thereof in Treatment of Lean Exhaust Gases - The invention provides a process for reducing the amounts of carbon monoxide, hydrocarbons and soot particles in the lean exhaust gas from an internal combustion engine using a particle filter, wherein the soot particles have a soot ignition temperature T | 2009-11-19 |
20090285737 | Copper CHA Zeolite Catalysts - Zeolite catalysts and systems and methods for preparing and using zeolite catalysts having the CHA crystal structure are disclosed. The catalysts can be used to remove nitrogen oxides from a gaseous medium across a broad temperature range and exhibit hydrothermal stable at high reaction temperatures. The zeolite catalysts include a zeolite carrier having a silica to alumina ratio from about 15:1 to about 256:1 and a copper to alumina ratio from about 0.25:1 to about 1:1. | 2009-11-19 |
20090285738 | Direct oxidation of sulfur with carbon dioxide recycle - A method for removing hydrogen sulfide to produce elemental sulfur from a synthesis gas feed stream containing hydrogen sulfide, carbon monoxide, hydrogen, carbon dioxide and water using direct oxidation of hydrogen sulfide by contacting a feed stream containing synthesis gas with oxygen in the presence of a catalyst comprised of metal oxides to convert a substantial fraction of the hydrogen sulfide present in the feed stream into sulfur and water, followed by cooling the reaction products to a temperature below the dew point temperature of the water and sulfur, separating the reaction products into two streams, with the first stream containing elemental sulfur and water in liquid form and the second stream containing unreacted components from the synthesis gas, hydrogen sulfide, carbon monoxide, hydrogen, carbon dioxide and water, and then recycling a portion of the unreacted components to the feed stream. | 2009-11-19 |
20090285739 | MITIGATING OR ELIMINATING THE CARBON FOOTPRINT OF HUMAN ACTIVITIES - A method for neutralizing or reducing the carbon footprint from carbon dioxide emissions due to human activities related to the combustion or use of carbon containing fuels. This method includes an initial step of capturing carbon dioxide and then chemically recycling it to form and provide a permanent inexhaustible supply of carbon containing fuels or products, which subsequently can be combusted or used without increasing the carbon dioxide content of the atmosphere. Thus, the current lifestyles that rely extensively on conventional carbon containing fuels and products can continue indefinitely without harming the environment to preserve and even improve the earth's atmosphere for the benefit of future generations. | 2009-11-19 |
20090285740 | CATALYTIC PROCESS FOR CONTROL OF NOx EMISSIONS USING HYDROGEN - A selective catalytic reduction process with a palladium catalyst for reducing NO | 2009-11-19 |
20090285741 | ALKALI RESISTANT CATALYST - The present invention concerns the selective removal of nitrogen oxides (NOx) from gasses. In particular, the invention concerns a process, a catalyst and the use of a catalyst for the selective removal of nitrogen oxides in the presence of ammonia from gases containing a significant amount of alkali metal and/or alkali-earth compounds which process comprises using a catalyst combined of (i) a formed porous superacidic support, said superacidic support having an Hammett acidity stronger than Ho=−12, and (ii) a metal oxide catalytic component deposited on said superacidic support selected from the group consisting of oxides of Fe, Cu, V, Cr, Mn, and any mixtures thereof. | 2009-11-19 |
20090285742 | Method of preparing zinc silicate-based phosphor and zinc silicate-based phosphor prepared using the method - Provided are a method of preparing a zinc silicate-based phosphor and a zinc silicate-based phosphor prepared using the method. The method includes: (a) preparing a solution including a Zn precursor compound and a Si precursor compound; (b) adding a coprecipitant to the solution to form precipitation; and (c) heat treating the solution in which the precipitation is formed to synthesize zinc silicate (Zn | 2009-11-19 |
20090285743 | METHOD FOR PRODUCING TRICHLOROSILANE AND APPARATUS FOR PRODUCING TRICHLOROSILANE - A method and an apparatus for producing trichlorosilane comprising: producing reaction product gas containing trichlorosilane and hydrogen chloride by initiating a reaction of silicon tetrachloride and hydrogen at 900° C. to 1900° C.; preventing a reverse reaction to silicon tetrachloride and by-production of a polymer by cooling the reaction product gas discharged from the reaction chamber to 300° C. to 800° C., thereby optimizing the cooling rate of the reaction gas; preheating at least one of the silicon tetrachloride and the hydrogen introduced into the reaction chamber | 2009-11-19 |
20090285744 | Process For Producing Fine Diamond and Fine Diamond - The present invention relates to a process for producing a fine diamond characterized by that an explosive composition containing a compound having an aliphatic hydrocarbon ring with 4 to 15 carbons, a fullerenes or a tubular or fiber carbon nanostructure having a diameter of 1 to 100 nm as a carbon raw material is exploded for explosive synthesis, and a fine diamond obtained by said process; the ultrafine particulate diamond of 1 to 3 nm is expected, as a single nano diamond, for application of the fields such as ultrafine processing, the uniform, spherical fine particulate diamond of 0.01 to 100 μm is expected as abrasive grains for polishing in precise processing and the like, and the needle diamond is expected for application in various sensors and the like. | 2009-11-19 |
20090285745 | Method for Production of Carbon Nanotube and Method for Purification of the Same - The present invention provides a method for producing a carbon nanotube having a high purity and a method for purifying an unpurified carbon nanotube or a carbon nanotube having a low purity. The method for producing a carbon nanotube comprises a step of providing a carbonaceous material containing a carbon nanotube and a step of adding an iron material and hydrogen peroxide to the carbonaceous material to thereby purity a carbon nanotube. It is preferred that an iron powder is used as the iron material. The iron powder is preferably used in a proportion of 0.5 to 20 parts by mass relative to 100 parts by mass of the whole carbonaceous material. | 2009-11-19 |
20090285746 | METHOD FOR TREATING CARBON NANOTUBES, CARBON NANOTUBES AND CARBON NANOTUBES DEVICE COMPRISING THEREOF - An efficient and cost-effective method for treating carbon nanotubes (CNTs) is provided. The method includes comprising: dispersing said carbon nanotubes in a dispersing medium to prepare a dispersion system; mixing said dispersion system with adsorbent so that type-specific carbon nanotubes contained in said dispersion system are absorbed onto the adsorbent, wherein the adsorbent is modified by a chemical/biological modifier so as to have different adsorption selectivity to carbon nanotubes of different types; and separating the adsorbent from the dispersion system, whereby the type-specific carbon nanotubes adsorbed onto the adsorbent is separated from the carbon nanotubes of another type enriched in the dispersion system; carbon nanotubes produced by the treatment method, and CNTs devices comprising thereof. | 2009-11-19 |
20090285747 | MICRO-DOMAIN GRAPHITIC MATERIALS AND METHOD FOR PRODUCING SAME - This invention relates to a method for producing micro-domain graphitic materials by use of a plasma process, and to novel micro-conical graphitic materials. By micro-domain graphitic material we mean fullerenes, carbon nanotubes, open conical carbon structures (also named micro-cones), preferably flat graphitic sheets, or a mixture of two or all of these. The novel carbon material is open carbon micro-cones with total disclination degrees of 60° and/or 120°, corresponding to cone angles of respectively 112.9° and/or 83.6°. | 2009-11-19 |
20090285748 | BARIUM TITANATE AND ELECTRONIC PARTS USING THE MATERIAL - A process for producing a single crystal barium titanate comprises reacting a titanium oxide sol obtained by a wet process and a water-soluble barium compound under the presence of a basic compound in an aqueous reaction mixture at a pH of at least 11 to form a slurry containing barium titanate. The aqueous reaction mixture is subjected to a solid-liquid separation to separate the barium titanate from the slurry. The basic compound is removed as a gas from the barium titanate, and the barium titanate is fired at 300-1200° C. | 2009-11-19 |
20090285749 | Apparatus and Method for Functional Neurological Screening - A variable focus collimator device and method for functional neurological screening. The variable focus collimator uses sets of corresponding holes in two plates of gamma shielding material, arranged so that only gamma rays emitted from a defined focal region detected. If a suitable radio-labeled tracer has been administered to the patient, this may be used to obtain and compare basal and stimulated data from a small number of regions in the brain to diagnose the presence or absence of dementias. The regions of the brain observer are typically about a cm cubed in volume, and their activity is monitored using small doses (<2 mCi) of radio-labeled, brain perfusion agents. The regions used are easily and repeatably located relative to well-known anthropological and radiological fiducials. By simply use of symmetry, ratios and cortical to cerebellar comparisons, rapid (˜15 minute) screening for dementia may be accomplished. | 2009-11-19 |
20090285750 | AGENT, COMPOSITION AND METHOD - The present application relates to agents, compositions and methods for use in medicine. In particular, the application relates to an agent comprising a binding moiety capable of selectively binding to Ku protein for use in medicine, in particular in the treatment and diagnosis of cancers. | 2009-11-19 |
20090285751 | CANCEROUS DISEASE MODIFYING ANTIBODIES - The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells. | 2009-11-19 |
20090285752 | IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS - The invention is directed to a method for treating a treating and diagnosing a B cell-related disease, T cell-related disease or an autoimmune disease in a mammal by concurrently or sequentially administering to the mammal a therapeutic composition that comprises a pharmaceutically acceptable vehicle and at least one conjugated antibody, wherein predosing with a non-radiolabeled antibody is not performed. | 2009-11-19 |
20090285753 | Novel haptotactic peptides - Novel cell attachment peptides having sequences homologous to specific portions of the carboxy terminal sequence of fibrinogen chains are disclosed. The novel peptides, derived from proteins related to fibrinogen including a peptide adjacent to fibrinogen γ-chain C terminus denoted pre-Cγ possess cell attraction activities, and are useful in pharmaceutical compositions. | 2009-11-19 |
20090285754 | PEPTIDES FOR TARGETING APOPTOTIC CELLS AND USES THEREOF - The present invention relates to a peptide capable of specifically targeting apoptotic cells undergoing apoptosis and a use thereof. More particularly, it relates to a peptide having an amino acid sequence represented by anyone selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 12 and targeting apoptotic cells, a composition for detection of apoptotic cells comprising the same as an effective ingredient, a composition for drug delivery comprising the same as an effective ingredient, a composition for imaging comprising the same as an effective ingredient and the like. The peptide of the present invention effectively detects apoptosis which is involved in tissues of neoplastic disease, myocardial infarction, stroke and arteriosclerosis. Accordingly, the peptide of the present invention may be used in imaging of diagnosis of the said diseases and reaction against a drug by binding imaging reagent and etc. as well as in protection and treatment for the said diseases by binding a treatment reagent and then delivering drug selectively. | 2009-11-19 |
20090285755 | METHODS FOR TUMOR DIAGNOSIS AND THERAPY - The present invention discloses a method for the enzyme-mediated, site-specific, in-vivo precipitation of a water soluble molecule in an animal. The enzyme is either unique to tumor cells, or is produced within a specific site (e.g., tumor) at concentrations that are higher than that in normal tissues. Alternatively, the enzyme is conjugated to a targeting moiety such as an antibody or a receptor-binding molecule. | 2009-11-19 |
20090285756 | 11C/18 F-LABELED INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3 - The present invention relates to new | 2009-11-19 |
20090285757 | METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY - Methods of making bispecific binding complexes and nanopolymers coupled to detection and/or therapeutic agents are disclosed. Also disclosed are methods of using such bispecific binding complexes and nanopolymers for detecting and treating cells. | 2009-11-19 |
20090285758 | IN VIVO SYSTEM TO MONITOR TISSUE RESPONSES IN BIRDS - Methods of evaluating the tissue response to an agent in birds are provided. Also disclosed are methods of monitoring exposure to agents in birds and methods of determining the efficacy of vaccines. | 2009-11-19 |
20090285759 | DRUG, DRUG GUIDANCE SYSTEM, MAGNETIC DETECTION SYSTEM, AND DRUG DESIGN METHOD - A drug comprises an organic or inorganic compound, and is made magnetic by modification of side chains and/or crosslinking between side chains. | 2009-11-19 |
20090285760 | METHOD FOR DETECTING CANCER USING ICG FLUORESCENCE METHOD - A method of detecting an accessory cancer lesion, comprising an administration step wherein indocyanine green is administered to a living body, an irradiation step wherein a target organ suspected of having cancer is surgically exposed and irradiated with excitation light of indocyanine green, an imaging step wherein a near-infrared fluorescence intensity distribution image from the excited indocyanine green in the target organ is obtained, and an identification step wherein an area having the near-infrared fluorescence in the intensity distribution image, excluding the area detected in preoperative examination or intraoperative macroscopic observation, is identified as an accessory cancer lesion. | 2009-11-19 |
20090285761 | Renal Function Analysis Method and Apparatus - A method for measuring a glomerular filtration rate in a mammalian kidney comprises a source of reporter and marker fluorescent molecules. The fluorescent molecules are introduced into the blood stream of a mammalian subject. Over a period of time, a measurement of the intensities of the reporter and marker fluorescent molecules is taken. A ratio is calculated to determine the health of the subject's kidney. This method measures volume of plasma distribution based on a fluorescence of a marker molecule relative to a fluorescence of a reporter molecule. | 2009-11-19 |
20090285762 | IMAGING METHODS AND COMPOSITIONS COMPRISING FLUORESCENT DYES ASSOCIATED WITH VIRAL COMPONENTS FOR NERVE IMAGING - Disclosed herein are compositions and methods for imaging nerve cells. The composition comprises a fluorescent dye; and a viral component selected from a neurotropic, replication-defective virus, a viral protein of a neurotropic virus, and a capsid of a neurotropic virus. Although the fluorescent dye in itself cannot penetrate nerve cells, the fluorescent dye is bound to the viral component to form a dye/viral component complex that is capable of penetrating nerve cells. | 2009-11-19 |
20090285763 | INFANT AEROSOL DRUG DELIVERY SYSTEMS AND METHODS - A delivery system and method for delivering an aerosol drug to an infant. The delivery device comprises a) a diagnostic module configured to provide geometrical properties of the nasal airway of the infant as output; b) a dosing system configured to produce an aerosol drug dose, based upon the output of the diagnostic module, that is predicted to ensure that a desired amount of the aerosol drug dose reaches the lungs of the infant in use; and c) an infant facemask connected to receive the aerosol drug dose from the dosing system for supply of the aerosol drug dose to the infant. | 2009-11-19 |
20090285764 | Azeotrope-Like Compositions of Tetrafluoropropene and Hydrofluorocarbons - Provided are azeotrope-like compositions comprising tetrafluoropropene and hydrofluorocarbons and uses thereof, including use in refrigerant compositions, refrigeration systems, blowing agent compositions, and aerosol propellants. | 2009-11-19 |
20090285765 | Hair Treatment Compositions - A hair treatment composition, comprising a silicone pressure sensitive adhesive wherein the composition comprises less than 0.5 wt % of water. | 2009-11-19 |
20090285766 | Photosensitising Composition and Uses Thereof - The present invention provides a photosensitising composition comprising a mixture of: at least one surfactant; at least one alcohol; and/or water, with the proviso that when the at least one surfactant is an alcohol, it is different from the at least one alcohol. In particular, the composition may comprise a mixture of glycerol, ethanol and water. Alternatively, the composition may comprise a mixture of polyethylene glycol, ethanol and water. The photosensitising composition may further comprise at least one photosensitising compound. The present invention also provides a method of treating and/or preventing conditions caused by microorganisms in a subject. | 2009-11-19 |
20090285767 | USE OF OZONATED LIQUIDS AND PEROXIDES TO WHITEN TEETH - A method for the whiting of teeth includes the delivery of ozone dissolved in a fluid to the tooth surface. The ozone treatment can be followed by the application to the tooth surface of peroxide based tooth whitening compositions, combined with the peroxide whitener or delivered to the tooth surface coated with the peroxide whitening agent. | 2009-11-19 |
20090285768 | Compositions and Methods Incorporating Photocatalysts - The various embodiments provide a composition including an active material having functional groups capable of covalent attachment to a substrate in the presence of an acid or a base, a photocatalyst capable of generating an acid or a base upon exposure to light, and a vehicle. The compositions may also include surfactants, emulsifiers, oxidants, and other components. A method for treating a substrate is also disclosed. The method includes the steps of applying at least one active material having functional groups to the substrate, applying a photocatalyst to the substrate, and exposing the photocatalyst and the at least one active material to light for forming covalent attachments between the functional groups and constituent groups on the substrate. The compositions and methods described herein are useful in personal care product and consumer care product applications, for example. | 2009-11-19 |
20090285769 | OXATHIANE DERIVATIVE AS PERFUMING INGREDIENT - The present invention relates to 2-(3-methylbutyl)-4-propyl-1,3-oxathiane and its use as perfuming ingredients. The present invention also concerns the use of this compound in the perfumery industry as well as the compositions or articles containing this compound. | 2009-11-19 |
20090285770 | Topical Compositions for Promoting Homeostasis of the Skin - The invention relates in particular to a composition for topical application to the skin, comprising, in a physiologically acceptable medium, at least one peptide increasing the expression of mechanoreceptors in the cells of the skin and at least one tensing agent. According to one alternative the agent increasing the expression of mechanoreceptors in the cells of the skin is selected from zinc salts, copper salts, manganese salts, derivatives thereof and mixtures thereof. The invention likewise relates to a skincare kit comprising at least two compositions comprising respectively the tensing agent and the agent increasing the expression of mechanoreceptors in the cells of the skin. The invention also relates to a method of cosmetic treatment of the skin that comprises simultaneous or sequential application of said compositions. | 2009-11-19 |
20090285771 | Methods and compositions for needleless delivery of macromolecules - Methods and compositions for needleless delivery of macromolecules to the bloodstream of a subject are provided herein. In one aspect, the invention provides a delivery construct, comprising a receptor binding domain, a transcytosis domain, a macromolecule to be delivered to a subject, and a cleavable linker. Generally, the cleavable linker is cleavable by an enzyme present in higher concentration at or near the basal-lateral membrane of a polarized epithelial cell or in the plasma than elsewhere in the body, for example, at the apical side of the polarized epithelial cell. In other aspects, the invention provides nucleic acids encoding delivery constructs of the invention, kits comprising delivery constructs of the invention, cells expressing delivery constructs of the invention, and methods of using delivery constructs of the invention. | 2009-11-19 |
20090285772 | QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION - Quinoline derivatives, particularly 4-anilinoquinoline derivatives, are provided. Such quinoline derivatives can be used for modulation of DNA methylation, such as effective inhibition of methylation of cytosine at the C-5 position, for example via selective inhibition of DNA methyltransferase DNMT1. Methods for synthesizing numerous 4-anilinoquinoline derivatives and for modulating DNA methylation are provided. Also provided are methods for formulating and administering these compounds or compositions to treat conditions such as cancer and hematological disorders. | 2009-11-19 |
20090285773 | Hepatitis C Virus Inhibitors - Hepatitis C virus inhibitors having the general formula | 2009-11-19 |
20090285774 | Hepatitis C Virus Inhibitors - Hepatitis C virus inhibitors having the general formula | 2009-11-19 |
20090285775 | TREATMENT OF WOUNDS USING IL-17B - IL-17B is known to stimulate the proliferation of chondrocytes, bone, and is highly expressed in nervous tissue, resulting in repair of diseased tissue. When IL-17B is absent a marked negative effect on wound healing is noted. The present invention comprises providing IL-17B, by topical, parental, or other administration means, in order to accelerate the wound healing process. The present invention further encompasses a pharmaceutical composition and formulations thereof that utilize IL-17B, either alone or in combination with other cytokines or growth factors known to aid wound healing. The invention also contemplates methods of treating wounds in patients using this pharmaceutical composition. | 2009-11-19 |
20090285776 | IRREVERSIBLY-INACTIVATED PEPSINOGEN FRAGMENTS FOR MODULATING IMMUNE FUNCTION - Isolated anti-cancer peptides are disclosed which are characterized by the amino acid sequences TLTSGGGAIALPPSMAAPPLGPVAPLTGAIHAPTXG; TLSTATGGAIPPVAAMPPGLVAPTHGPAIHP; CCATSGPCGAVMILTPHLTA; MTLTTGSGAIAPAMPPGLPPHTGAIHAPM; and NXVPVSVEGYXQITLDSITX and a significant in vitro binding affinity for gp96. The peptides exhibit anti-tumor, anti-cancer activity in vivo. Also disclosed is an isolated antiviral peptide is characterized by the amino acid sequence GDEPLENYLDTEYF and a significant in vitro binding affinity for HIV-1 gp 120 and gp 41, and human CD4 cells. The peptide exhibits anti-retroviral activity in vivo, particularly anti-HIV-1 activity. | 2009-11-19 |
20090285777 | Uses of Mammalian Cytokine; Related Reagents - Provided are methods of treatment for skin disorders. In particular, treatment, the skin disorders are generally inflammatory skin disorders, including improper wound healing. Provided are methods of using of a cytokine molecule. | 2009-11-19 |
20090285778 | USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER - The present invention relates to the anti-cancer activity of IL-19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of cervical cancer cells, treating cervical cancer, amongst other uses disclosed. IL-19 polypeptides can be administered alone, or can be fused to cytotoxic moieties, and can be administered in conjunction with radiation or chemotherapeutic agents. | 2009-11-19 |
20090285779 | INDUCTION OF APOPTOSIS IN TOLL-LIKE RECEPTOR EXPRESSING TUMOR CELLS - Some types of cancer cells express one or more Toll-like receptors (TLRs). These TLRs are therapeutic targets. The invention relates to methods for treating Toll-like receptor expressing cancers and tumor cells by selecting a TLR expressing tumor cell and contacting the cell with a therapeutically effective amount of a TLR ligand. The invention particularly relates to methods for treating TLR3 expressing cancers and tumor cells using TLR3 agonists. | 2009-11-19 |
20090285780 | PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF - PEG linker compounds and biologically active conjugates thereof having mixed functional group linkages attached to at least one PEG moeity, and a coupling group for attaching a biologically active molecule. The PEG mixed linkages can be the combinations of stable, or labile, or releasable, or stable and labile, or stable and releasable, or releasable and labile covalent linkages. The mixed functional linkages of the PEG linker compounds consist of different organic functional groups, which have non-equivalent half-life in plasma and, hence, they have different release rates in blood. The present invention also provides for attachment of novel PEG linker compounds with mixed functional linkages for Pegylation of biologically active molecules to produce Probiomolecule-PEG constructs. The Probiomolecule-PEG construct is the prodrug of biomolecule-PEG conjugate or biomolecule. The Probiomolecule-PEG conjugate will gradually lose portions (or all) of its PEG polymers in vivo to convert into smaller size biomolecule-PEG conjugate (or biologically active molecule), thereby increasing their biological activity in vivo. | 2009-11-19 |
20090285781 | Medicament and a method of treating a pathological syndrome - A medicament based on antibodies contains an activated form of monoclonal, polyclonal, or natural antibodies to interferon in low or ultra-low doses prepared by multiple consecutive dilutions and exposure to external factors, preferably in accordance with homeopathic technology. In order to obtain antibodies, human or heterologous interferon alpha, beta, or gamma, including recombinant interferon, is used; a mixture of various, mostly centimal, homeopathic dilutions being employed. A method of treating a pathologic syndrome, whose formation is affected by interferon, consists in the use of activated forms of antibodies to interferon alpha, beta, or gamma in low or ultra-low doses obtained by multiple consecutive dilutions and exposure to external factors. | 2009-11-19 |
20090285782 | 4,6-DI- AND 2,4,6-TRISUBSTITUTED QUINAZOLINE DERIVATIVES USEFUL FOR TREATING VIRAL INFECTIONS - This invention provides quinazoline derivatives represented by the structural formula: (I); wherein: R | 2009-11-19 |
20090285783 | Methods and compositions for cancer therapy using a novel adenovirus - The invention comprises a novel virus that can kill mammalian cancer cells efficiently. The virus produces a novel protein that converts two non-toxic prodrugs into potent chemotherapeutic agents. These chemotherapeutic agents are produced locally and help the virus kill the cancer cells as well as sensitize them to radiation. In preclinical studies, the virus has proven effective at killing a variety of mammalian cancer cells either alone or when combined with prodrug therapy and/or radiation therapy. The invention may provide a safe and effective treatment for human cancer. | 2009-11-19 |
20090285784 | DSRNA As Insect Control Agent - The present invention concerns methods for controlling insect infestation via RNAi-mediated gene silencing, whereby the intact insect cell(s) are contacted with a double-stranded RNA from outside the insect cell(s) and whereby the double-stranded RNA is taken up by the intact insect cell(s). In one particular embodiment, the methods of the invention are used to alleviate plants from insect pests. Alternatively, the methods are used for treating and/or preventing insect infestation on a substrate or a subject in need of such treatment and/or prevention. Suitable insect target genes and fragments thereof, dsRNA constructs, recombinant constructs and compositions are disclosed. | 2009-11-19 |
20090285785 | External Agent for Treatment of Skin Ulcer - [Problems] To provide a novel external agent for treatment of skin ulcer which has an excellent healing effect on intractable skin ulcer such as bedsore, diabetic skin ulcer and ischemic skin ulcer. | 2009-11-19 |
20090285786 | METHOD TO MODULATE HEMATOPOIETIC STEM CELL GROWTH - The present invention provides for compositions and methods for modulating hematopoietic stem cell populations by using HCS modulators, which are agents that either increase HSC numbers or decrease HSC numbers as desired by a particular indication. For example, HSC modulators found to increase HSC numbers include prostaglandin E2 (PGE2) and agents that stimulate the PGE2 pathway. Conversely, HSC modulators that prevent PGE2 synthesis decrease HSC numbers. HCS modulators may be used in vitro, in vivo, or ex vivo. | 2009-11-19 |
20090285787 | Intracoronary, intracardia, or intravenous infusion of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium - The present invention is a method for improving cardiac function and myocardial regeneration in living subjects after the occurrence of myocardial infarction. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged myocardium. Studies have shown that the implant improves heart function and myocardial regeneration as assessed by MRI, SPECT and echocardiographic measurements. | 2009-11-19 |
20090285788 | RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME - This invention provides expression vectors for a ribonucleic acid (RNA) molecule comprising a double-stranded region of random sequence, sets and libraries of same, methods of generating same, and methods for identifying an RNA therapeutic or RNA molecule that has an ability to affect a biological parameter, for identifying a drug target for a disease or disorder of interest, and for identifying a variant of an RNA molecule that has an altered ability to affect a biological parameter of interest. | 2009-11-19 |
20090285789 | METHODS FOR ENHANCING INNATE AND ADAPTIVE IMMUNITY AND ANTIGEN IMMUNOGENICITY - The present invention is related to a method for enhancing innate and adaptive immunity by activating dendritic cells (DCs) and macrophages, comprising administering a subject LZ-8 protein. The present invention is also related to a composition for enhancing innate and adaptive immunity, comprising LZ-8 protein. | 2009-11-19 |
20090285790 | METHODS OF TREATING AND DIAGNOSING PARKINSONS DISEASE AND RELATED DYSAUTONOMIC DISORDERS - A method for treating a Parkinson's patient with digestive/pancreatic enzymes involves administering an effective amount of digestive/pancreatic enzymes to an individual having the disorder in order to improve a symptom of the disorder. In addition, a method is provided for determining whether an individual has, or may develop, Parkinson's disease or related dysautonomic disorders and for determining whether an individual will benefit from the administration of pancreatic/digestive enzymes to treat the dysautonomic disorder. | 2009-11-19 |
20090285791 | Regenerating and enhancing development of muscle tissue - Muscle tissue regeneration is one of the most important homeostatic processes of adult skeletal muscle, which after development retains the capacity to regenerate in response to different type of stimuli, including a direct trauma or neurological dysfunction; atrophy; and genetic defects. The present invention pertains to cdk9-55 and its ability to regenerate muscle tissue and enhance development. Cdk9-55 is specifically induced upon satellite cell differentiation and is necessary for the gene expression reprogramming required to complete the regeneration process. | 2009-11-19 |
20090285792 | Compositions and methods for treatment of neovascular diseases - The present invention provides compositions and methods of treating neovascular diseases, such as a retinal neovascular diseases and tumors, by administering to a patient suffering from a neovascular disease or tumor a vascular development inhibiting amount of a combination of the angiogenesis suppressing drugs comprising an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and at least one compound selected from the group consisting of a vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor. Compositions for use in the methods include an admixture of an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and at least one of a vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor, together with a pharmaceutically acceptable excipient. | 2009-11-19 |
20090285793 | Novel thrombolytic enzyme and a process for its preparation - The invention relates to a thrombolytic enzyme referred to as Thrombinase having a molecular weight of 31,000 to 32,000. Such a thrombolytic enzyme can be used for dissolving blood clots. The process comprises culturing a filtrate of Bacillus sphaericus sero type H5a 5b, removing the cell, subjecting the cell supernatant to filtration, salting out the retentate, subjecting the precipitate to dialysis, reprecipitating the precipitate and then reconstituting in buffer and finally decolourizing, purifying and dialyzing. | 2009-11-19 |
20090285794 | Novel non-antibiotic strategy against OGIP infections based on an activated cereal product or ferric quinate - The present invention refers to a non-antibiotic therapeutic strategy for inhibiting oro-gastro-intestinal infections and pathogens in general and particularly | 2009-11-19 |
20090285795 | Method for the Production of a Monoclonal Antibody to CD20 for the Treatment of B-Cell Lymphoma - The present invention relates to the recombinant method used for the production of soluble form of an antibody that binds to CD20 for treatment of patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphoma (NHL). The treatment will comprise the use of immunologically active anti-CD20 antibodies; or radiolabeled anti-CD20 antibodies and or cooperative strategies where both labeled and non-labeled antibodies will be used for treatment of NHL. The procedure describes the de novo synthesis of the nucleic acid sequence encoding anti-CD20, transformation of the constructed nucleic acid sequences into competent bacteria and the sub-cloning of the same into mammalian expression vectors for expression of the desired protein. DNA constructs comprising the control elements associated with the gene of interest has been disclosed. The nucleic acid sequence of interest has been codon optimized to permit expression in the suitable mammalian host cells. | 2009-11-19 |
20090285796 | MUTANT JAK3 KINASE IN HUMAN LEUKEMIA - In accordance with the invention, a novel activating mutation (alanine 572 to valine) in JAK3 kinase has been discovered in human acute myelogenous leukemia (AML). The mutant JAK3 kinase was confirmed to drive the proliferation and survival of acute megakaryoblastic leukemia (AML-M7). The invention therefore provides, in part, isolated polynucleotides and vectors encoding the disclosed mutant JAK3 kinase polypeptides, probes for detecting it, isolated mutant polypeptides, recombinant polypeptides, and reagents for detecting the mutant polypeptides. The disclosed identification of this new mutant protein and enables new methods for determining the presence of mutant JAK3 kinase polypeptides in a biological sample, methods for screening for compounds that inhibit the mutant proteins, and methods for inhibiting the progression of a cancer characterized by the mutant polynucleotides or polypeptides, which are also provided by the invention. | 2009-11-19 |
20090285797 | USE OF INHIBITORS OF CYP2A6 FOR REGULATING NICOTINE METABOLISM - The invention relates to methods and compositions for regulating nicotine metabolism. Also provided are methods for screening and assessing substances for regulating nicotine metabolism. Methods are provided for assessing nicotine metabolism. | 2009-11-19 |